XGN
Exagen Inc.
Diagnostics & Research · Healthcare · United States
8.59
close · 2026-10-30
value
5
cheaper than peers5
quality
8
stronger fundamentals8
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| price to sales | 3.04× | 66 |
| price to book | 17.01× | 22 |
| cash flow yield, 2 years ago | -7.3% | 18 |
| earnings yield, 2 years ago | -15.6% | 18 |
| cash flow yield, 3 years ago | -17.5% | 15 |
| cash flow yield, latest year | -6.9% | 15 |
| earnings yield, latest year | -10.8% | 15 |
| earnings yield, 1 year ago | -9.7% | 15 |
| earnings yield, 3 years ago | -32.2% | 12 |
| cash flow yield, 1 year ago | -6.6% | 11 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 11.7% | 56 |
| operating margin | -19.7% | 28 |
| debt to equity | 188.1% | 12 |
| return on equity | -193.6% | 5 |
4 of 4 measures available
Facts
| market cap | $208M |
| free cash flow | -$9.1M |
| employees | 216 |
| first trade | 2019-09-19 |
| next earnings | 2026-11-10 |
| fundamentals updated | 2026-08-04 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.93 | -0.83 | -1.34 | -2.77 |
| free cash flow | -$14.3M | -$13.8M | -$15.3M | -$36.5M |
| net income | -$20.0M | -$15.1M | -$23.7M | -$47.4M |
| revenue | $66.6M | $55.6M | $52.5M | $45.6M |
| unusual items | -$1.8M | $0 | $0 | -$5.5M |